MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.70 +0.25 (+2.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Preferred Shares (2021)

Updated

MoonLake Immunotherapeutics (MLTX) reported Preferred Shares of $72,466 for Q4 2021.

Analysis

MoonLake Immunotherapeutics (MLTX) Preferred Shares (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 72,466.00
API Access

MoonLake Immunotherapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=MLTX&period=max&api_key=YOUR_API_KEY